Sheila Arquette, president and CEO of the National Association of Specialty Pharmacy, tells this week’s Video Forum about recent developments in specialty pharmacy. Among the subjects she addresses are what community pharmacies can do to raise their profile in specialty Rx, the importance of coordination across the continuum of care, the impact of biosimilars, and the challenge of maximizing value for both patients and the health care system.
Video Forum: Sheila Arquette, NASP
Sheila Arquette, president and CEO of the National Association of Specialty Pharmacy, tells this week’s Video Forum about recent developments in specialty pharmacy.
Related
Kroger-Albertsons merger goes on trial in an Oregon federal court
The FTC faces off against lawyers from Albertsons and Kroger in a fight over competition in the grocery channel.
FDA approves Moderna’s updated COVID-19 vaccine
Moderna's updated COVID-19 vaccine targets the KP.2 variant of SARS-CoV-2 to help prevent COVID-19 in individuals 6 months of age and older.
Kroger sues FTC, claims merger challenge violates Constitution
The company argues that by proceeding in its administrative tribunal, in addition to the separate action in federal court, the FTC is violating Constitutional protections.
CRN to Federal Appeals Court: NY AG’s arguments don’t support denial of preliminary injunction in NY age restrictions case
CRN’s most recent brief argues that the NY AG does not meaningfully address CRN’s arguments about the Act’s constitutional infirmities.
Latest
Reese's rolls out Filled Pretzels
The secret to this treat? A thick and creamy peanut butter filling that delivers Reese's iconic taste. The snack aisle just got a lot more awesome.
CHPA lauds lawmakers for urging FDA to safeguard Rx-OTC pathway
“It cannot be emphasized enough how vital expanded access to OTC medicines is to public health, and the Rx-to-OTC switch process has delivered safe, effective, and affordable options for decades.”
Camber launches Lurasidone Hydrochloride Tablets
Lurasidone Hydrochloride Tablets are an atypical antipsychotic indicated for the treatment of Schizophrenia in adults and adolescents (13 to 17 years) and other depressive episodes.
NRF releases statement supporting federal legislation to combat retail crime
“We urge Congress to move quickly to approve this integral measure.”